We are live on
!
Find out more
RAM
Rempart Asset Management Portfolio holdings
AUM
$488M
1-Year Est. Return
20.68%
This Fund
S&P 500
This Quarter
Est. Return
+15.46%
1 Year Est. Return
+20.68%
3 Year Est. Return
+58.85%
5 Year Est. Return
+79.62%
10 Year Est. Return
–
AUM
$352M
AUM Growth
–
Cap. Flow
+$330M
Cap. Flow
% of AUM
93.66%
Top 10 Holdings %
Top 10 Hldgs %
58.88%
Holding
36
New
36
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$26.1M |
| 2 |
Microsoft
MSFT
|
+$25.6M |
| 3 |
Costco
COST
|
+$22.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$18.4M |
| 5 |
Colgate-Palmolive
CL
|
+$18M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 27.63% |
| 2 | Healthcare | 16.79% |
| 3 | Consumer Staples | 12.28% |
| 4 | Industrials | 9.31% |
| 5 | Financials | 9.12% |
Similar funds
KCM
MHR
HL
UOIF
ACA
ACM
SCA
GCM
Rempart Asset Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Rempart Asset Management, which disclosed 36 positions worth $352M. Its ten largest holdings account for 59% of the portfolio.
Its largest position is Thermo Fisher Scientific: 55,600 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Healthcare and Consumer Staples.
- Rempart Asset Management's largest Q4 2020 buy was Thermo Fisher Scientific: 55,600 shares worth $25.9M.
- Rempart Asset Management's ten largest holdings make up 59% of its $352M portfolio in Q4 2020.
- Rempart Asset Management disclosed 36 positions in Q4 2020, its first 13F filing on record.
Based on Rempart Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.